T
TEVA
Teva Pharmaceutical Industries Limited
$40.72
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Teva Pharmaceutical Industries Limited in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
$0.60
P/E
64.1
Data as of Oct 1
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: $0.73
Nov 3
Posts
No posts about TEVA yet.
About Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries is an Israel-based drugmaker and one of the world's largest sellers of generic medicines, the cheaper copies of brand-name drugs that hit the market once the original patent expires. Alongside its huge generics business, Teva also sells its own branded specialty drugs, including treatments for multiple sclerosis and migraine, which carry higher profit margins than generics.